This may lead to a decrease in luminal cells, along with an increase in basal intermediate prostate CSCs and AR-negative PCa cells, which exhibit a high proliferation index and repopulate the tumor through transit to the luminal layer, thus giving rise to CRPC [36]. The gene discussed is AR; the disease is posterior cortical atrophy.